Skip to contentS
Surgery Partners, Inc.
S
SGRYSurgery Partners, Inc. Q3 2021 · 10-Q
Revenue$559.20M$559.20M+12.7% vs Q3 2020 Net Income-$22.90M-$22.90MN/M vs Q3 2020 EPS Diluted-$0.28-$0.28N/M vs Q3 2020 Operating Income$63,600,000+243.8% Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Surgery Partners, Inc. · CIK 1638833 · Engraved from SEC EDGAR
derived
Free Cash Flowderived-$600,000N/M Margins · derivedOperating margin11.4%+7.6 pt vs Q3 2020
Net margin-4.1%+8.3 pt vs Q3 2020
ended Sep 30, 2021 · filed Nov 3, 2021 · 34 d after period end